Olmesartan Medoxomil
Back to searchMolecule Structure
Scientific Name
Olmesartan Medoxomil
Brand Name(s)
Benicar, Olmesartan medoxomil, Olmetec
Company Owner(s)
Sunshine Lake Pharma Co Ltd, Alkem Laboratories Ltd, Qilu Pharmaceutical Co Ltd, Jubilant Generics Ltd, Macleods Pharmaceuticals Ltd, Mylan Pharmaceuticals Inc, Zydus Pharmaceuticals Usa Inc, Prinston Pharmaceutical Inc, Inventia Healthcare Ltd, Torrent Pharmaceuticals Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Type-1 angiotensin II receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL227 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL16403 | ||
PharmGKB | PA164742950 | ||
Human Metabolome Database | HMDB0255956 | ||
PubChem: Thomson Pharma | 14935211 | ||
PubChem | 130881 | ||
Mcule | MCULE-2480015750 | ||
LINCS | LSM-3767 | ||
Nikkaji | J689.130F | ||
BindingDB | 50442892 | ||
EPA CompTox Dashboard | DTXSID9045924 | ||
DrugCentral | 1985 | ||
Brenda | 154392 | 153407 | 14931 |
ChemicalBook | CB8254825 | ||
Guide to Pharmacology | 591 | ||
rxnorm | OLMESARTAN MEDOXOMIL | BENICAR | |
PubChem: Drugs of the Future | 12014934 | ||
ChEBI | 31932 | ||
ZINC | ZINC000004149248 |